Ruthenium Red: High-Fidelity Ca2+ Transport Inhibitor for Research

Executive Summary: Ruthenium Red is a benchmark Ca2+ transport inhibitor, exhibiting nanomolar to millimolar affinity for two distinct Ca2+-binding sites on the sarcoplasmic reticulum (SR) Ca2+-ATPase enzyme (source: product_spec). By blocking mitochondrial, erythrocyte, and SR calcium flux, it enables rigorous interrogation of cytoskeleton-dependent mechanotransduction and autophagy (source: paper). Ruthenium Red is water-soluble, stable at room temperature, and achieves full neurogenic inflammation inhibition in vivo at 5 μmol/kg (source: product_spec). Its precise mechanism and robust performance are validated by peer-reviewed studies and APExBIO's standardized B6740 product line.

Biological Rationale

Intracellular calcium (Ca2+) flux orchestrates vital processes including autophagy, muscle contraction, and cellular response to mechanical stress. The sarcoplasmic reticulum (SR) and mitochondria are primary Ca2+ reservoirs, regulated by high-affinity Ca2+-ATPase channels. Disruption or modulation of these pathways is crucial for dissecting cytoskeleton-dependent signaling and mechanotransduction, as established in recent autophagy research (source: paper). Ruthenium Red provides a tool to block Ca2+ uptake and channel activity, permitting controlled perturbation of calcium signaling pathways in experimental models (source: internal_article).

Mechanism of Action of Ruthenium Red

Ruthenium Red binds two distinct Ca2+-binding sites on the SR Ca2+-ATPase enzyme. The first site exhibits a dissociation constant (Km) of 4.5 μM, and the second site has a Km of 2.0 mM (source: product_spec). These sites reside within helical segments of the transmembrane domain, forming a functional Ca2+ channel. Ruthenium Red blocks Ca2+ transport in a concentration-dependent manner, reducing the SR vesicles' capacity to bind calcium. This blockade affects not only the SR but also mitochondrial and erythrocyte membranes, making Ruthenium Red a general inhibitor of Ca2+ flux (source: internal_article). Complete inhibition of neurogenic inflammation is documented at 5 μmol/kg in rat trachea models (source: product_spec).

Evidence & Benchmarks

• Ruthenium Red binds to two high-affinity Ca2+-binding sites on the SR Ca2+-ATPase, with Km values of 4.5 μM and 2.0 mM under physiological buffer, pH 7.4 (source: product_spec).
• It inhibits mitochondrial calcium uptake and erythrocyte Ca2+ transport at low micromolar concentrations (source: internal_article).
• Ruthenium Red achieves complete inhibition of capsaicin-induced plasma extravasation in rat trachea at 5 μmol/kg, administered intraperitoneally (source: product_spec).
• In cytoskeleton-dependent autophagy studies, Ca2+ channel blockade by Ruthenium Red allows precise mapping of mechanotransduction pathways (source: paper).
• Water solubility is ≥7.86 mg/mL at room temperature; compound is insoluble in DMSO and ethanol, enabling aqueous workflow compatibility (source: product_spec).
• For further application protocols, see "Ruthenium Red (SKU B6740): Reliable Ca2+ Transport Inhibitor for Cytoskeleton & Autophagy Assays" which details troubleshooting and data interpretation (internal_article).

This article extends previous coverage (e.g., Ruthenium Red: Advanced Calcium Transport Inhibitor for Mechanistic Cell Biology) by providing protocol-ready benchmarks and novel evidence integration for cytoskeleton-mechanotransduction pathways.

Applications, Limits & Misconceptions

Ruthenium Red is widely used in calcium signaling research, mitochondrial calcium uptake inhibition, and neurogenic inflammation inhibition. Its specificity for dual Ca2+-ATPase sites makes it suitable for dissecting complex calcium signaling pathways in cell lines and tissue preparations. However, its application is limited to in vitro and animal model research. The compound is not suitable for diagnostic or therapeutic use in humans (source: product_spec).

Common Pitfalls or Misconceptions

• Ruthenium Red solutions are unstable over long-term storage; fresh solutions are recommended for each experiment (source: product_spec).
• The compound is insoluble in DMSO and ethanol; aqueous buffers must be used (source: product_spec).
• It is not selective for a single Ca2+ channel subtype; effects may reflect general Ca2+ flux inhibition (source: internal_article).
• Not for diagnostic or medical use; research-only (source: product_spec).
• High concentrations may cause off-target effects in cellular assays; titration is recommended (workflow_recommendation).

Workflow Integration & Parameters

Protocol Parameters

• SR Ca2+ uptake assay | 1-10 μM Ruthenium Red | in vitro SR vesicles | enables rapid, concentration-dependent Ca2+ channel blockade | product_spec
• Neurogenic inflammation inhibition | 5 μmol/kg i.p. | rat trachea model | achieves complete capsaicin-induced extravasation suppression | product_spec
• Autophagy induction mapping | 2–10 μM | cell culture, human lines | blocks Ca2+ influx to clarify cytoskeleton-mechanotransduction | paper
• Storage | solid at room temperature | all workflows | ensures activity; avoid long-term solution storage | product_spec
• Solubility | ≥7.86 mg/mL in water | aqueous assays only | DMSO/ethanol not compatible; use fresh water solutions | product_spec

For troubleshooting, see the Q&A section of "Ruthenium Red (SKU B6740): Resolving Calcium Signaling and Autophagy Assay Design" (internal_article), which details experimental pain points and workflow optimization.

Conclusion & Outlook

Ruthenium Red, as supplied by APExBIO, is a high-affinity, dual-site Ca2+ transport inhibitor with robust evidence backing its role in calcium signaling and cytoskeleton-dependent autophagy research. Its precise mechanism and reproducibility make it indispensable for dissecting mechanotransduction and inflammation pathways in cell biology. Future research will expand on its applications in mapping force-induced autophagic signaling, as highlighted by recent mechanobiology studies (source: paper). Limitations remain in clinical translation and selectivity, but the compound's reliability in experimental systems is well established.